{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T08:03:01Z","timestamp":1772438581287,"version":"3.50.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01804-0","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T07:29:23Z","timestamp":1772436563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-translational modifications in alzheimer\u2019s disease: proteome dynamics and emerging therapeutic strategies"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4242-3584","authenticated-orcid":false,"given":"Shareen","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0732-4592","authenticated-orcid":false,"given":"Amritpal","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3705-1539","authenticated-orcid":false,"given":"Souvik","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Twinkle","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"1804_CR1","doi-asserted-by":"publisher","first-page":"743573","DOI":"10.3389\/FNAGI.2021.743573","volume":"13","author":"NZ Abuelezz","year":"2021","unstructured":"Abuelezz NZ, Nasr FE, AbdulKader MA et al (2021) MicroRNAs as potential orchestrators of alzheimer\u2019s Disease-Related pathologies: insights on current status and future possibilities. Front Aging Neurosci 13:743573. https:\/\/doi.org\/10.3389\/FNAGI.2021.743573","journal-title":"Front Aging Neurosci"},{"key":"1804_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/S10571-022-01299-0","volume":"43","author":"RR Agrawal","year":"2022","unstructured":"Agrawal RR, Larrea D, Xu Y et al (2022) Alzheimer\u2019s-Associated upregulation of Mitochondria-Associated ER membranes after traumatic brain injury. Cell Mol Neurobiol 2022 43:5. https:\/\/doi.org\/10.1007\/S10571-022-01299-0","journal-title":"Cell Mol Neurobiol 2022"},{"issue":"1 45","key":"1804_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/S10571-025-01554-0","volume":"45","author":"SM Alqahtani","year":"2025","unstructured":"Alqahtani SM, Al-Kuraishy HM, Al-Gareeb AI et al (2025) Targeting of PP2 A\/GSK3\u03b2\/PTEN axis in alzheimer disease: the mooting Evidence, Divine, and devil. Cell Mol Neurobiol 2025 45(1 45):36. https:\/\/doi.org\/10.1007\/S10571-025-01554-0","journal-title":"Cell Mol Neurobiol 2025"},{"key":"1804_CR4","doi-asserted-by":"publisher","first-page":"595532","DOI":"10.3389\/FNEUR.2020.595532","volume":"11","author":"C Alquezar","year":"2021","unstructured":"Alquezar C, Arya S, Kao AW (2021) Tau Post-translational modifications: dynamic Transformers of Tau Function, Degradation, and aggregation. Front Neurol 11:595532. https:\/\/doi.org\/10.3389\/FNEUR.2020.595532","journal-title":"Front Neurol"},{"key":"1804_CR5","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.4103\/1673-5374.393106","volume":"19","author":"VC Alves","year":"2024","unstructured":"Alves VC, Carro E, Figueiro-Silva J (2024) Unveiling DNA methylation in alzheimer\u2019s disease: a review of array-based human brain studies. Neural Regen Res 19:2365\u20132376. https:\/\/doi.org\/10.4103\/1673-5374.393106","journal-title":"Neural Regen Res"},{"key":"1804_CR6","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/PTR.6642","volume":"34","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M, Rafiei H, Mohammadinejad R et al (2020) Potential therapeutic effects of Curcumin mediated by JAK\/STAT signaling pathway: A review. Phytother Res 34:1745\u20131760. https:\/\/doi.org\/10.1002\/PTR.6642","journal-title":"Phytother Res"},{"issue":"1","key":"1804_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13024-021-00474-Z","volume":"16","author":"B Bai","year":"2021","unstructured":"Bai B, Vanderwall D, Li Y et al (2021) Proteomic landscape of alzheimer\u2019s disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegeneration 2021 16(1):1\u201316. https:\/\/doi.org\/10.1186\/S13024-021-00474-Z","journal-title":"Mol Neurodegeneration 2021"},{"key":"1804_CR8","doi-asserted-by":"publisher","first-page":"916063","DOI":"10.3389\/FMOLB.2022.916063","volume":"9","author":"A Baier","year":"2022","unstructured":"Baier A, Szyszka R (2022) CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders. Front Mol Biosci 9:916063. https:\/\/doi.org\/10.3389\/FMOLB.2022.916063","journal-title":"Front Mol Biosci"},{"key":"1804_CR9","doi-asserted-by":"publisher","unstructured":"Balmik AA, Chinnathambi S (2021) Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer\u2019s disease. Cell Communication and Signaling 2021 19:1 19:51-. https:\/\/doi.org\/10.1186\/S12964-021-00732-Z","DOI":"10.1186\/S12964-021-00732-Z"},{"key":"1804_CR10","doi-asserted-by":"publisher","first-page":"9067","DOI":"10.3390\/IJMS24109067","volume":"24","author":"D Baracaldo-Santamar\u00eda","year":"2023","unstructured":"Baracaldo-Santamar\u00eda D, Avenda\u00f1o-Lopez SS, Ariza-Salamanca DF et al (2023) Role of calcium modulation in the pathophysiology and treatment of alzheimer\u2019s disease. Int J Mol Sci 24:9067. https:\/\/doi.org\/10.3390\/IJMS24109067","journal-title":"Int J Mol Sci"},{"key":"1804_CR11","doi-asserted-by":"publisher","first-page":"1675598","DOI":"10.3389\/FPHYS.2025.1675598","volume":"16","author":"A Bertozzi","year":"2025","unstructured":"Bertozzi A, Toscanelli W, Castellitto G et al (2025) SUMOylation balance: a key determinant in synapse physiology. Front Physiol 16:1675598. https:\/\/doi.org\/10.3389\/FPHYS.2025.1675598","journal-title":"Front Physiol"},{"key":"1804_CR12","doi-asserted-by":"publisher","unstructured":"Buszka A, Pyty\u015b A, Colvin D et al (2023) S-Palmitoylation of synaptic proteins in neuronal plasticity in normal and pathological brains. Cells 2023 12. https:\/\/doi.org\/10.3390\/CELLS12030387","DOI":"10.3390\/CELLS12030387"},{"key":"1804_CR13","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/JNR.23576","volume":"93","author":"JF Castro-Alvarez","year":"2015","unstructured":"Castro-Alvarez JF, Uribe-Arias A, Cardona-G\u00f3mez GP (2015) Cyclin-Dependent kinase 5 targeting prevents \u03b2-Amyloid aggregation involving glycogen synthase kinase 3\u03b2 and phosphatases. J Neurosci Res 93:1258\u20131266. https:\/\/doi.org\/10.1002\/JNR.23576","journal-title":"J Neurosci Res"},{"key":"1804_CR14","doi-asserted-by":"publisher","unstructured":"Chen W, Zhao H, Li Y (2023) Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduction and Targeted Therapy 2023 8:1 8:333-. https:\/\/doi.org\/10.1038\/s41392-023-01547-9","DOI":"10.1038\/s41392-023-01547-9"},{"key":"1804_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13024-022-00561-9","volume":"17","author":"LK Cuddy","year":"2022","unstructured":"Cuddy LK, Alia AO, Salvo MA et al (2022) Farnesyltransferase inhibitor LNK-754 attenuates axonal dystrophy and reduces amyloid pathology in mice. Mol Neurodegeneration 2022 17:1. https:\/\/doi.org\/10.1186\/S13024-022-00561-9","journal-title":"Mol Neurodegeneration 2022"},{"key":"1804_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/IJMS22115911","volume":"22","author":"SR D\u2019mello","year":"2021","unstructured":"D\u2019mello SR (2021) When good kinases go rogue: GSK3, p38 MAPK and CDKs as therapeutic targets for alzheimer\u2019s and huntington\u2019s disease. Int J Mol Sci 2021 22:22. https:\/\/doi.org\/10.3390\/IJMS22115911","journal-title":"Int J Mol Sci 2021"},{"key":"1804_CR17","doi-asserted-by":"publisher","unstructured":"Dongdem JT, Dawson SP, Layfield R et al (2024) Ubiquitin: structure and function. https:\/\/doi.org\/10.5772\/INTECHOPEN.112091","DOI":"10.5772\/INTECHOPEN.112091"},{"key":"1804_CR19","doi-asserted-by":"publisher","unstructured":"Dunning EE, Decourt B, Zawia NH et al (2024) Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review. Neurology and Therapy 2024 13:4 13:975\u20131013. https:\/\/doi.org\/10.1007\/S40120-024-00614-9","DOI":"10.1007\/S40120-024-00614-9"},{"key":"1804_CR18","doi-asserted-by":"publisher","unstructured":"Du Y, Yu Z, Li C et al (2025) The role of Statins in dementia or alzheimer\u2019s disease incidence: a systematic review and meta-analysis of cohort studies. Front Pharmacol 16. https:\/\/doi.org\/10.3389\/FPHAR.2025.1473796","DOI":"10.3389\/FPHAR.2025.1473796"},{"key":"1804_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-3-030-49844-3_11","volume":"1275","author":"AB Engin","year":"2021","unstructured":"Engin AB, Engin A (2021) Alzheimer\u2019s disease and protein kinases. Adv Exp Med Biol 1275:285\u2013321. https:\/\/doi.org\/10.1007\/978-3-030-49844-3_11","journal-title":"Adv Exp Med Biol"},{"issue":"1 11","key":"1804_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/S13195-019-0530-Z","volume":"2019 11","author":"JB Foster","year":"2019","unstructured":"Foster JB, Lashley R, Zhao F et al (2019) Enhancement of tripartite synapses as a potential therapeutic strategy for alzheimer\u2019s disease: a preclinical study in rTg4510 mice. Alzheimer\u2019s Res Therapy 2019 11(1 11):75\u2013. https:\/\/doi.org\/10.1186\/S13195-019-0530-Z","journal-title":"Alzheimer\u2019s Res Therapy"},{"key":"1804_CR22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/S12031-018-1174-3\/METRICS","volume":"66","author":"NV Gorantla","year":"2018","unstructured":"Gorantla NV, Chinnathambi S (2018) Tau protein squired by molecular chaperones during alzheimer\u2019s disease. J Mol Neurosci 66:356\u2013368. https:\/\/doi.org\/10.1007\/S12031-018-1174-3\/METRICS","journal-title":"J Mol Neurosci"},{"key":"1804_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3233\/ADR-180089","volume":"3","author":"FX Guix","year":"2019","unstructured":"Guix FX, Sart\u00f3rio CL, Ill-Raga G (2019) BACE1 translation: at the crossroads between alzheimer\u2019s disease neurodegeneration and memory consolidation. J Alzheimers Dis Rep 3:113\u2013148. https:\/\/doi.org\/10.3233\/ADR-180089;REQUESTEDJOURNAL:JOURNAL:ALRA;WEBSITE:WEBSITE:SAGE;ISSUE:ISSUE:DOI","journal-title":"J Alzheimers Dis Rep"},{"key":"1804_CR24","doi-asserted-by":"publisher","unstructured":"Hamano T, Enomoto S, Shirafuji N et al (2021) Autophagy and Tau Protein. Int J Mol Sci 2021 22:7475. https:\/\/doi.org\/10.3390\/IJMS22147475","DOI":"10.3390\/IJMS22147475"},{"key":"1804_CR25","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/J.BIOPSYCH.2020.02.001","volume":"89","author":"H Hampel","year":"2021","unstructured":"Hampel H, Vassar R, De Strooper B et al (2021) The \u03b2-Secretase BACE1 in alzheimer\u2019s disease. Biol Psychiatry 89:745\u2013756. https:\/\/doi.org\/10.1016\/J.BIOPSYCH.2020.02.001","journal-title":"Biol Psychiatry"},{"key":"1804_CR26","doi-asserted-by":"publisher","unstructured":"Hassan M, Yasir M, Shahzadi S et al (2024a) Molecular Role of Protein Phosphatases in Alzheimer\u2019s and Other Neurodegenerative Diseases. Biomedicines 2024, Vol 12, Page 1097 12:1097. https:\/\/doi.org\/10.3390\/BIOMEDICINES12051097","DOI":"10.3390\/BIOMEDICINES12051097"},{"key":"1804_CR27","doi-asserted-by":"publisher","unstructured":"Hassan M, Yasir M, Shahzadi S et al (2024b) Molecular Role of Protein Phosphatases in Alzheimer\u2019s and Other Neurodegenerative Diseases. Biomedicines 2024, Vol 12, 12:. https:\/\/doi.org\/10.3390\/BIOMEDICINES12051097","DOI":"10.3390\/BIOMEDICINES12051097"},{"key":"1804_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tins.2018.02.004","volume":"41","author":"JM Henley","year":"2018","unstructured":"Henley JM, Carmichael RE, Wilkinson KA (2018) Extranuclear sumoylation in neurons. Trends Neurosci 41:198\u2013210. https:\/\/doi.org\/10.1016\/j.tins.2018.02.004","journal-title":"Trends Neurosci"},{"key":"1804_CR29","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/J.CHEMBIOL.2021.03.009","volume":"28","author":"LT Henneberg","year":"2021","unstructured":"Henneberg LT, Schulman BA (2021) Decoding the messaging of the ubiquitin system using chemical and protein probes. Cell Chem Biol 28:889\u2013902. https:\/\/doi.org\/10.1016\/J.CHEMBIOL.2021.03.009","journal-title":"Cell Chem Biol"},{"issue":"8:1","key":"1804_CR30","doi-asserted-by":"publisher","first-page":"8O17","DOI":"10.1186\/1750-1326-8-S1-O17","volume":"2013","author":"H Hering","year":"2013","unstructured":"Hering H, Graham D, Ousson S et al (2013) Novel non-carbohydrate O-GlcNAcase inhibitors with CNS drug properties as potential treatment for alzheimer\u2019s disease and tauopathies. Mol Neurodegeneration 2013(8:1):8O17\u2013. https:\/\/doi.org\/10.1186\/1750-1326-8-S1-O17","journal-title":"Mol Neurodegeneration"},{"key":"1804_CR31","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/J.1476-5381.2010.01014.X","volume":"161","author":"M Hiramatsu","year":"2010","unstructured":"Hiramatsu M, Takiguchi O, Nishiyama A, Mori H (2010) Cilostazol prevents amyloid \u03b2 peptide(25\u201335)-induced memory impairment and oxidative stress in mice. Br J Pharmacol 161:1899\u20131912. https:\/\/doi.org\/10.1111\/J.1476-5381.2010.01014.X","journal-title":"Br J Pharmacol"},{"key":"1804_CR32","doi-asserted-by":"publisher","unstructured":"Jadiya P, Garbincius JF, Elrod JW (2021) Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling. Acta Neuropathologica Communications 2021 9:1 9:124-. https:\/\/doi.org\/10.1186\/S40478-021-01224-4","DOI":"10.1186\/S40478-021-01224-4"},{"key":"1804_CR33","doi-asserted-by":"publisher","unstructured":"Jia F, Fu L (2025) Roles of Ubiquitin Ligases and Deubiquitylases in Alzheimer\u2019s Disease. Molecular Neurobiology 2025 62:6 62:7747\u20137761. https:\/\/doi.org\/10.1007\/S12035-025-04739-2","DOI":"10.1007\/S12035-025-04739-2"},{"key":"1804_CR34","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1002\/JCP.30122","volume":"236","author":"J Jin","year":"2021","unstructured":"Jin J, Zhi X, Wang X, Meng D (2021) Protein palmitoylation and its pathophysiological relevance. J Cell Physiol 236:3220\u20133233. https:\/\/doi.org\/10.1002\/JCP.30122","journal-title":"J Cell Physiol"},{"key":"1804_CR35","doi-asserted-by":"publisher","first-page":"e70046","DOI":"10.1002\/JNR.70046","volume":"103","author":"S Kelliny","year":"2025","unstructured":"Kelliny S, Zhou XF, Bobrovskaya L (2025) Alzheimer\u2019s disease and frontotemporal dementia: A review of pathophysiology and therapeutic approaches. J Neurosci Res 103:e70046. https:\/\/doi.org\/10.1002\/JNR.70046","journal-title":"J Neurosci Res"},{"key":"1804_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/SCITRANSLMED.AAD9704","author":"ME Kennedy","year":"2016","unstructured":"Kennedy ME, Stamford AW, Chen X et al (2016) The BACE1 inhibitor verubecestat (MK-8931) reduces CNS \u03b2-amyloid in animal models and in alzheimer\u2019s disease patients. Sci Transl Med. https:\/\/doi.org\/10.1126\/SCITRANSLMED.AAD9704. 8:","journal-title":"Sci Transl Med"},{"key":"1804_CR37","doi-asserted-by":"publisher","first-page":"e70020","DOI":"10.1002\/TRC2.70020","volume":"10","author":"W Kielbasa","year":"2024","unstructured":"Kielbasa W, Goldsmith P, Donnelly KB et al (2024) Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of alzheimer\u2019s disease. Alzheimer\u2019s Dementia: Translational Res Clin Interventions 10:e70020. https:\/\/doi.org\/10.1002\/TRC2.70020","journal-title":"Alzheimer\u2019s Dementia: Translational Res Clin Interventions"},{"key":"1804_CR38","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/NPP.2009.197","volume":"35","author":"M Kilgore","year":"2010","unstructured":"Kilgore M, Miller CA, Fass DM et al (2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of alzheimer\u2019s disease. Neuropsychopharmacology 35:870\u2013880. https:\/\/doi.org\/10.1038\/NPP.2009.197","journal-title":"Neuropsychopharmacology"},{"key":"1804_CR39","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3233\/JAD-181219\/SUPPL_FILE\/SJ-DOCX-1-ALZ-10.3233_JAD-181219.DOCX","volume":"68","author":"D Kumar","year":"2019","unstructured":"Kumar D, Kumar P (2019) Integrated mechanism of lysine 351, PARK2, and STUB1 in A\u03b2PP ubiquitination. J Alzheimer\u2019s Disease 68:1125\u20131150. https:\/\/doi.org\/10.3233\/JAD-181219\/SUPPL_FILE\/SJ-DOCX-1-ALZ-10.3233_JAD-181219.DOCX","journal-title":"J Alzheimer\u2019s Disease"},{"key":"1804_CR40","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s13311-018-00708-x","volume":"16","author":"JY Lee","year":"2019","unstructured":"Lee JY, Lee H, Yoo H, Bin et al (2019) Efficacy of cilostazol administration in alzheimer\u2019s disease patients with white matter lesions: A Positron-Emission tomography study. Neurotherapeutics 16:394\u2013403. https:\/\/doi.org\/10.1007\/s13311-018-00708-x","journal-title":"Neurotherapeutics"},{"issue":"1 4","key":"1804_CR41","doi-asserted-by":"publisher","first-page":"7190","DOI":"10.1038\/srep07190","volume":"4","author":"L Lee","year":"2014","unstructured":"Lee L, Dale E, Staniszewski A et al (2014) Regulation of synaptic plasticity and cognition by SUMO in normal physiology and alzheimer\u2019s disease. Sci Rep 2014 4(1 4):7190\u2013. https:\/\/doi.org\/10.1038\/srep07190","journal-title":"Sci Rep 2014"},{"key":"1804_CR42","doi-asserted-by":"publisher","unstructured":"Li L, Zhang W, Cheng S et al (2012) Isoprenoids and Related Pharmacological Interventions: Potential Application in Alzheimer\u2019s Disease. Molecular Neurobiology 2012 46:1 46:64\u201377. https:\/\/doi.org\/10.1007\/S12035-012-8253-1","DOI":"10.1007\/S12035-012-8253-1"},{"key":"1804_CR43","doi-asserted-by":"publisher","unstructured":"Li X, Han J, Bujaranipalli S et al (2022) Structure-based discovery and development of novel O-GlcNAcase inhibitors for the treatment of alzheimer\u2019s disease. Eur J Med Chem 238. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114444","DOI":"10.1016\/j.ejmech.2022.114444"},{"key":"1804_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JAD-141959","volume":"45","author":"S Lovestone","year":"2015","unstructured":"Lovestone S, Boada M, Dubois B et al (2015) A phase II trial of Tideglusib in alzheimer\u2019s disease. J Alzheimers Dis 45:75\u201388. https:\/\/doi.org\/10.3233\/JAD-141959","journal-title":"J Alzheimers Dis"},{"key":"1804_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/J.TRCI.2015.08.001","volume":"1","author":"T Majid","year":"2015","unstructured":"Majid T, Griffin D, Criss Z et al (2015) Pharmocologic treatment with histone deacetylase 6 inhibitor (ACY-738) recovers alzheimer\u2019s disease phenotype in amyloid precursor protein\/presenilin 1 (APP\/PS1) mice. Alzheimers Dement (N Y) 1:170\u2013181. https:\/\/doi.org\/10.1016\/J.TRCI.2015.08.001","journal-title":"Alzheimers Dement (N Y)"},{"key":"1804_CR46","doi-asserted-by":"publisher","unstructured":"Mandel N, Agarwal N, Mandel N, Agarwal N (2022) Role of sumoylation in neurodegenerative diseases. Cells 2022. https:\/\/doi.org\/10.3390\/CELLS11213395","DOI":"10.3390\/CELLS11213395"},{"key":"1804_CR47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2174\/1567205014666170505095109\/CITE\/REFWORKS","volume":"15","author":"S Marcelli","year":"2017","unstructured":"Marcelli S, Corbo M, Iannuzzi F et al (2017) The involvement of Post-Translational modifications in alzheimer\u2019s disease. Curr Alzheimer Res 15:313\u2013335. https:\/\/doi.org\/10.2174\/1567205014666170505095109\/CITE\/REFWORKS","journal-title":"Curr Alzheimer Res"},{"key":"1804_CR48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2174\/1567205014666170505095109","volume":"15","author":"S Marcelli","year":"2018","unstructured":"Marcelli S, Corbo M, Iannuzzi F et al (2018) The involvement of Post-Translational modifications in alzheimer\u2019s disease. Curr Alzheimer Res 15:313\u2013335. https:\/\/doi.org\/10.2174\/1567205014666170505095109","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"1804_CR49","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/S11064-015-1681-3","volume":"41","author":"WC Martins","year":"2015","unstructured":"Martins WC, Tasca CI, Cimarosti H (2015) Battling alzheimer\u2019s disease: targeting SUMOylation-Mediated pathways. Neurochemical Res 2015 41(3):568\u2013578. https:\/\/doi.org\/10.1007\/S11064-015-1681-3","journal-title":"Neurochemical Res 2015"},{"key":"1804_CR50","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1523\/JNEUROSCI.4129-14.2015","volume":"35","author":"PC May","year":"2015","unstructured":"May PC, Willis BA, Lowe SL et al (2015) The potent BACE1 inhibitor LY2886721 elicits robust central A\u03b2 pharmacodynamic responses in mice, dogs, and humans. J Neurosci 35:1199\u20131210. https:\/\/doi.org\/10.1523\/JNEUROSCI.4129-14.2015","journal-title":"J Neurosci"},{"key":"1804_CR51","doi-asserted-by":"publisher","unstructured":"Mondal P, Bai P, Gomm A et al (2024) Structure-Based discovery of A small molecule inhibitor of histone deacetylase 6 (HDAC6) that significantly reduces alzheimer\u2019s disease neuropathology. Adv Sci (Weinh) 11. https:\/\/doi.org\/10.1002\/ADVS.202304545","DOI":"10.1002\/ADVS.202304545"},{"key":"1804_CR52","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/BIOF.1930","volume":"49","author":"G Montalto","year":"2023","unstructured":"Montalto G, Ricciarelli R (2023) Tau, Tau kinases, and Tauopathies: an updated overview. BioFactors 49:502\u2013511. https:\/\/doi.org\/10.1002\/BIOF.1930","journal-title":"BioFactors"},{"key":"1804_CR53","doi-asserted-by":"publisher","first-page":"977411","DOI":"10.3389\/FNAGI.2022.977411","volume":"14","author":"I Mumtaz","year":"2022","unstructured":"Mumtaz I, Ayaz MO, Khan MS et al (2022) Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of alzheimer\u2019s disease. Front Aging Neurosci 14:977411. https:\/\/doi.org\/10.3389\/FNAGI.2022.977411","journal-title":"Front Aging Neurosci"},{"key":"1804_CR54","doi-asserted-by":"publisher","unstructured":"Oriquat G, Abdulsahib WK, Jyothi SR et al (2025) miR-132 and Its Exosomal Form in Alzheimer\u2019s Disease: Linking Epigenetic Regulation to Neurodegeneration. Molecular Neurobiology 2025 63:1 63:185-. https:\/\/doi.org\/10.1007\/S12035-025-05513-0","DOI":"10.1007\/S12035-025-05513-0"},{"key":"1804_CR55","doi-asserted-by":"publisher","unstructured":"Orobets KS, Karamyshev AL, Orobets KS, Karamyshev AL (2023) Amyloid precursor protein and alzheimer\u2019s disease. Int J Mol Sci 2023 24. https:\/\/doi.org\/10.3390\/IJMS241914794","DOI":"10.3390\/IJMS241914794"},{"key":"1804_CR56","doi-asserted-by":"publisher","unstructured":"Palabiyik AA, Palabiyik E (2025) Proteomics in biomarker discovery: uncovering disease-specific interactome and post-translational modification networks. Journal of Proteins and Proteomics 2025 1\u201315. https:\/\/doi.org\/10.1007\/S42485-025-00190-Y","DOI":"10.1007\/S42485-025-00190-Y"},{"key":"1804_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S11658-024-00625-2","volume":"29","author":"J Peng","year":"2024","unstructured":"Peng J, Liang D, Zhang Z (2024) Palmitoylation of synaptic proteins: roles in functional regulation and pathogenesis of neurodegenerative diseases. Cell Mol Biology Lett 2024 29:1. https:\/\/doi.org\/10.1186\/S11658-024-00625-2","journal-title":"Cell Mol Biology Lett 2024"},{"key":"1804_CR58","doi-asserted-by":"publisher","unstructured":"Plano LM, De, Saitta A, Oddo S et al (2024) Epigenetic Changes in Alzheimer\u2019s Disease: DNA Methylation and Histone Modification. Cells 2024. https:\/\/doi.org\/10.3390\/CELLS13080719","DOI":"10.3390\/CELLS13080719"},{"key":"1804_CR59","doi-asserted-by":"publisher","unstructured":"Prins ND, Harrison JE, Chu HM et al (2021) A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild alzheimer\u2019s disease. Alzheimers Res Ther 13. https:\/\/doi.org\/10.1186\/S13195-021-00843-2","DOI":"10.1186\/S13195-021-00843-2"},{"key":"1804_CR60","doi-asserted-by":"publisher","first-page":"e70096","DOI":"10.1002\/MCO2.70096","volume":"6","author":"YR Qian","year":"2025","unstructured":"Qian YR, Zhao YJ, Zhang F (2025) Protein palmitoylation: biological functions, disease, and therapeutic targets. MedComm (Beijing) 6:e70096. https:\/\/doi.org\/10.1002\/MCO2.70096","journal-title":"MedComm (Beijing)"},{"key":"1804_CR61","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/CBIC.201900573","volume":"21","author":"M Ramesh","year":"2020","unstructured":"Ramesh M, Gopinath P, Govindaraju T (2020) Role of Post-translational modifications in alzheimer\u2019s disease. ChemBioChem 21:1052\u20131079. https:\/\/doi.org\/10.1002\/CBIC.201900573","journal-title":"ChemBioChem"},{"key":"1804_CR62","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.3390\/IJMS232112841","volume":"23","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J et al (2022a) Phosphorylated Tau in alzheimer\u2019s disease and other tauopathies. Int J Mol Sci 2022 23:12841. https:\/\/doi.org\/10.3390\/IJMS232112841","journal-title":"Int J Mol Sci 2022"},{"key":"1804_CR63","doi-asserted-by":"publisher","unstructured":"Rawat P, Sehar U, Bisht J et al (2022b) Phosphorylated Tau in Alzheimer\u2019s Disease and Other Tauopathies. International Journal of Molecular Sciences 2022. https:\/\/doi.org\/10.3390\/IJMS232112841","DOI":"10.3390\/IJMS232112841"},{"key":"1804_CR64","doi-asserted-by":"publisher","first-page":"704","DOI":"10.30491\/IJMR.2024.455238.1280","volume":"11","author":"M Review","year":"2024","unstructured":"Review M, Abbasbeigi S (2024) A brief look at the enigma of protein aggregation: unraveling Mechanisms, exploring Implications, and proposing therapeutic strategies. Int J Med Reviews 11:704\u2013709. https:\/\/doi.org\/10.30491\/IJMR.2024.455238.1280","journal-title":"Int J Med Reviews"},{"key":"1804_CR65","doi-asserted-by":"publisher","first-page":"10062","DOI":"10.1021\/ACS.JMEDCHEM.9B01090","volume":"62","author":"HG Selnick","year":"2019","unstructured":"Selnick HG, Hess JF, Tang C et al (2019) Discovery of MK-8719, a potent O-GlcNAcase inhibitor as a potential treatment for tauopathies. J Med Chem 62:10062\u201310097. https:\/\/doi.org\/10.1021\/ACS.JMEDCHEM.9B01090","journal-title":"J Med Chem"},{"issue":"1 9","key":"1804_CR66","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41420-023-01343-y","volume":"9","author":"C Shan","year":"2023","unstructured":"Shan C, Zhang D, Ma D, ni et al (2023) Osteocalcin ameliorates cognitive dysfunctions in a mouse model of alzheimer\u2019s disease by reducing amyloid \u03b2 burden and upregulating Glycolysis in neuroglia. Cell Death Discovery 2023 9(1 9):46\u2013. https:\/\/doi.org\/10.1038\/s41420-023-01343-y","journal-title":"Cell Death Discovery 2023"},{"key":"1804_CR67","doi-asserted-by":"publisher","first-page":"106153","DOI":"10.1016\/J.PHRS.2022.106153","volume":"178","author":"T Sun","year":"2022","unstructured":"Sun T, Zhao K, Liu M et al (2022) miR-30a-5p induces A\u03b2 production via inhibiting the nonamyloidogenic pathway in alzheimer\u2019s disease. Pharmacol Res 178:106153. https:\/\/doi.org\/10.1016\/J.PHRS.2022.106153","journal-title":"Pharmacol Res"},{"key":"1804_CR68","doi-asserted-by":"publisher","first-page":"e13430","DOI":"10.1111\/OBR.13430","volume":"23","author":"HA Taylor","year":"2022","unstructured":"Taylor HA, Przemylska L, Clavane EM, Meakin PJ (2022) BACE1: more than just a \u03b2-secretase. Obes Rev 23:e13430. https:\/\/doi.org\/10.1111\/OBR.13430","journal-title":"Obes Rev"},{"key":"1804_CR69","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/ACEL.12473","volume":"15","author":"V Triaca","year":"2016","unstructured":"Triaca V, Sposato V, Bolasco G et al (2016) NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for alzheimer\u2019s disease. Aging Cell 15:661\u2013672. https:\/\/doi.org\/10.1111\/ACEL.12473;ISSUE:ISSUE:DOI","journal-title":"Aging Cell"},{"key":"1804_CR70","doi-asserted-by":"publisher","unstructured":"Tripathi K, Ben-Shachar D, Tripathi K, Ben-Shachar D (2024) Mitochondria in the central nervous system in health and disease: the puzzle of the therapeutic potential of mitochondrial transplantation. Cells 2024. https:\/\/doi.org\/10.3390\/CELLS13050410","DOI":"10.3390\/CELLS13050410"},{"issue":"1","key":"1804_CR71","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","volume":"19","author":"M Tzioras","year":"2022","unstructured":"Tzioras M, McGeachan RI, Durrant CS, Spires-Jones TL (2022) Synaptic degeneration in alzheimer disease. Nat Reviews Neurol 2022 19(1):19\u201338. https:\/\/doi.org\/10.1038\/s41582-022-00749-z","journal-title":"Nat Reviews Neurol 2022"},{"key":"1804_CR72","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.molcel.2017.07.018","volume":"67","author":"ZH Wang","year":"2017","unstructured":"Wang ZH, Liu P, Liu X et al (2017) Delta-Secretase phosphorylation by SRPK2 enhances its enzymatic Activity, provoking pathogenesis in alzheimer\u2019s disease. Mol Cell 67:812\u2013825e5. https:\/\/doi.org\/10.1016\/j.molcel.2017.07.018","journal-title":"Mol Cell"},{"key":"1804_CR73","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2174\/1570159X19666210121163224\/CITE\/REFWORKS","volume":"20","author":"W Wen","year":"2021","unstructured":"Wen W, Li P, Liu P et al (2021) Post-Translational modifications of BACE1 in alzheimer\u2019s disease. Curr Neuropharmacol 20:211\u2013222. https:\/\/doi.org\/10.2174\/1570159X19666210121163224\/CITE\/REFWORKS","journal-title":"Curr Neuropharmacol"},{"key":"1804_CR74","doi-asserted-by":"publisher","unstructured":"Wu X, Yang Z, Zou J et al (2025) Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery. Signal Transduction and Targeted Therapy 2025 10:1 10:1\u201338. https:\/\/doi.org\/10.1038\/s41392-025-02179-x","DOI":"10.1038\/s41392-025-02179-x"},{"key":"1804_CR75","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/S11427-015-4836-1","volume":"58","author":"N Xu","year":"2015","unstructured":"Xu N, Shen N, Wang XX et al (2015) Protein prenylation and human diseases: a balance of protein farnesylation and geranylgeranylation. Sci China Life Sci 2015 58:4. https:\/\/doi.org\/10.1007\/S11427-015-4836-1","journal-title":"Sci China Life Sci 2015"},{"key":"1804_CR76","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/S43556-021-00043-2","volume":"2","author":"Q Yang","year":"2021","unstructured":"Yang Q, Zhao J, Chen D, Wang Y (2021) E3 ubiquitin ligases: styles, structures and functions. Mol Biomed 2:23. https:\/\/doi.org\/10.1186\/S43556-021-00043-2","journal-title":"Mol Biomed"},{"key":"1804_CR77","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.4103\/1673-5374.385847","volume":"19","author":"J Ye","year":"2024","unstructured":"Ye J, Wan H, Chen S, Liu GP (2024) Targeting Tau in alzheimer\u2019s disease: from mechanisms to clinical therapy. Neural Regen Res 19:1489\u20131498. https:\/\/doi.org\/10.4103\/1673-5374.385847","journal-title":"Neural Regen Res"},{"key":"1804_CR78","unstructured":"Zachara NE, Akimoto Y, Boyce M, Hart GW (2022) The O-GlcNAc modification. Essentials of Glycobiology"},{"key":"1804_CR79","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.7150\/IJBS.57078","volume":"17","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wei W, Zhao M et al (2021) Interaction between A\u03b2 and Tau in the pathogenesis of alzheimer\u2019s disease. Int J Biol Sci 17:2181. https:\/\/doi.org\/10.7150\/IJBS.57078","journal-title":"Int J Biol Sci"},{"key":"1804_CR80","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/IJMS21010209","volume":"21","author":"T Zhang","year":"2019","unstructured":"Zhang T, Chen D, Lee TH et al (2019) Phosphorylation signaling in APP processing in alzheimer\u2019s disease. Int J Mol Sci 2020 21:21. https:\/\/doi.org\/10.3390\/IJMS21010209","journal-title":"Int J Mol Sci 2020"},{"key":"1804_CR81","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1515\/REVNEURO-2017-0013","volume":"28","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Chen X, Zhao Y et al (2017) The role of ubiquitin proteasomal system and autophagy-lysosome pathway in alzheimer\u2019s disease. Rev Neurosci 28:861\u2013868. https:\/\/doi.org\/10.1515\/REVNEURO-2017-0013","journal-title":"Rev Neurosci"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01804-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01804-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01804-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T07:29:27Z","timestamp":1772436567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01804-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1804"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01804-0","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}